Statistics
Publications
2
Citations
89
H-Index
2
Active since
2020
Lukas Arendt is an author at AstraZeneca (Sweden) specializing in hippo signaling pathway, drug-target interaction mapping, and molecular oncology.
Publications per year
2020–2020
2
2
1–2 of 2